title: Bullous lesions at polyethylene glycol interferon-alpha-2a inoculation site in a hepatitis C virus-infected subject.
authors.forename: M Antonietta
authors.initials: MA
authors.lastname: Montesu
authors.forename: Valentina
authors.initials: V
authors.lastname: Siddi
authors.forename: Rosanna
authors.initials: R
authors.lastname: Satta
authors.forename: Caterina
authors.initials: C
authors.lastname: Pirodda
authors.forename: Francesca
authors.initials: F
authors.lastname: Cottoni
mesh_terms: D000998:Antiviral Agents / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D007279:Injections, Subcutaneous; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage / Q000009:adverse effects*; D008875:Middle Aged; D011092:Polyethylene Glycols / Q000008:administration & dosage / Q000009:adverse effects*; D011994:Recombinant Proteins; D012872:Skin Diseases, Vesiculobullous / Q000139:chemically induced*
chemical_list: D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; C100416:peginterferon alfa-2a